Effectiveness of the BNT162b2 (COMIRNATY) vaccination in protecting from death due to COVID-19 in Poland: epidemiologic commentary and limitations

Pol Arch Intern Med. 2023 Sep 29;133(9):16574. doi: 10.20452/pamw.16574. Epub 2023 Sep 29.

Author

Andrzej Jarynowski¹

Affiliation

¹ System Modeling Group, Institute of Veterinary Epidemiology and Biostatistics, Freie Universität Berlin, Berlin, Germany; Interdisciplinary Research Institute, Wrocław, Poland; Aidmed, Gdańsk, Poland. ajarynowski@gmail.com

PMID: 37772713
DOI: 10.20452/pamw.16574

No abstract available

Publication types

Comment

MeSH terms

BNT162 Vaccine*
COVID-19* / prevention & control
Humans
Poland / epidemiology
Vaccination

Substances

BNT162 Vaccine